Latest Options News

Resolution Minerals has clarified its compliance with ASX disclosure rules following a $2 million placement to Tribeca Investment Partners, confirming the transaction's material impact on its share price.

EBOS Group Limited has updated its Dividend Reinvestment Plan rules, offering shareholders new ways to reinvest dividends into additional shares. The changes, effective immediately, provide greater flexibility and maintain board discretion over share issuance terms.

Chimeric Therapeutics reports promising interim results from its CHM CDH17 Phase 1/2 trial, with 75% disease control at 28 days and durable responses in gastrointestinal cancers.

Stellar Resources has raised an extra A$500,000 through a placement to a major shareholder, adding to a recent $12.4 million capital influx aimed at advancing its Heemskirk Tin Project in Tasmania amid robust tin market demand.

Jindalee Lithium Limited reminds eligible shareholders that its Share Purchase Plan (SPP) will close on 20 November 2025, offering shares at $0.55 each with free attaching options exercisable at $0.825. This follows a recent $8 million placement aimed at advancing key lithium projects.

Evergreen Lithium has formalised a binding option to acquire up to 100% of the Mt Monger Gold Project in Western Australia, reinforcing its strategic expansion in the prolific Goldfields region.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, finding limited competition concerns amid evolving digital media landscapes.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, citing limited competition concerns amid evolving digital media landscapes.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Antilles Gold has launched a substantial infill drilling program at its La Demajagua mine in Cuba, setting the stage for a Definitive Feasibility Study that could unlock enhanced resource value amid soaring gold, silver, and antimony prices.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

ADX Energy has raised A$3.5 million through a placement to fund key gas exploration projects in Austria and Italy, alongside plans for a strategic dual listing in Oslo.